Surmodics/ US8688731004 /
| 2024-06-07 9:59:55 PM | Chg. -0.01 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 41.97USD | -0.01% | 3,377 Turnover: 141,709.25 |
-Bid Size: - | -Ask Size: - | 598.21 mill.USD | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -0.11 USD | -94.39% |
| EPS Diluted: | -0.11 USD | -94.39% |
| Revenues per Share: | 9.37 USD | 31.56% |
| Book Value per Share: | 8.47 USD | 9.72% |
| Cash Flow per Share: | 0.74 USD | - |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 132.58 USD | 32.65% |
| Net Income: | -1.54 USD | -94.37% |
| Operating Cash Flow: | 10.51 USD | - |
| Cash and Cash Equivalents: | 41.42 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 4.48 | 3.43 |
| P/BV ratio: | 4.95 | 3.79 |
| P/CF Ratio: | 56.48 | 43.21 |
| PEG: | 4.04 | - |
| Earnings Yield: | -0.26% | -0.34% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 598.21 mill. USD | 454.27 mill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 14.26 mill. | |
Profitability
| Gross Profit Margin: | 81.17% |
| EBIT Margin: | 3.88% |
| Net Profit Margin: | -1.16% |
| Return on Equity: | -1.28% |
| Return on Assets: | -0.83% |
Financial Strength
| Liquidity I / Cash Ratio: | 172.91% |
| Liquidity II / Quick Ratio: | 218.21% |
| Liquidity III / Current Ratio: | 361.91% |
| Debt / Equity Ratio: | 54.89% |
| Dynam. Debt / Equity Ratio: | 626.05% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-09-30 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
